• Exchange: Helsinki
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Biotie Therapies OYJ

+ Add to Watchlist

BTH1V:FH

0.2030 EUR 0.0010 0.50%

As of 11:30:00 ET on 11/20/2014.

Snapshot for Biotie Therapies OYJ (BTH1V)

Open: 0.2020 Day's Range: 0.2000 - 0.2040 Volume: 223,834
Previous Close: 0.2020 52wk Range: 0.1820 - 0.3600 1-Yr Rtn: -32.33%

Stock Chart for BTH1V

No chart data available.
  • BTH1V:FH 0.2030
  • 1D
  • 1M
  • 1Y
0.2020
Interactive BTH1V Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTH1V

Current P/E Ratio (ttm) 164.2395
Estimated P/E(12/2014) -
Relative P/E vs. HEXP 7.4054
Earnings Per Share (EUR) (ttm) 0.0012
Est. EPS (EUR) (12/2014) -0.0140
Est. PEG Ratio -
Market Cap (M EUR) 92.57
Shares Outstanding (M) 456.03
30 Day Average Volume 337,697
Price/Book (mrq) 1.0801
Price/Sale (ttm) 4.8943
Dividend Indicated Gross Yield -%
Cash Dividend (EUR) -
Dividend Ex-Date 03/30/2006
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTH1V

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for BTH1V

Biotie Therapies Oyj is a biopharmaceutical company. The Company develops drugs that treat dependence disorders, inflammatory diseases, and thrombosis.

Timo VeromaaPresident/CEODavid CookCFO/Chief Business Ofcr
Stephen I BandakChief Medical OfficerIan J MasseyPresident:US Operations/COO
More Company Profile & Key Executives for BTH1V

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil